Insulin-like growth factors and their transporter proteins in the liver of rats with experimental diabetes, adenocarcinoma of the uterine corpus, and their combination

Aim. To investigate the content of insulin-like growth factor (IGF)-1, IGF-2, and their transporter proteins IGFBP-1 and IGFBP in the liver of rats with experimental diabetes, Guerin’s carcinoma, and their combination.Materials and methods. The experiment was carried out on 64 white outbred rats of both sexes, which were divided into 4 groups of 8 animals each: group 1 – intact animals, group 2 – animals with experimental diabetes, group 3 – animals with subcutaneously inoculated Guerin’s carcinoma, group 4 – animals with experimental diabetes and subcutaneously inoculated Guerin’s carcinoma. In the study, biochemical and statistical analyses and enzyme immunoassays were performed.Results. In the liver of the outbred rats, sex specificity in the content of insulin-like growth factors and IGFBP-1 was established: the levels of IGF-1, IGF-2, and IGFBP-1 in males were lower than in females. It was shown that the development of diabetes mellitus and the growth of Guerin’s carcinoma led to changes in the sex-specific components in the rat liver.Conclusion. The growth of Guerin’s carcinoma and the progression of diabetes mellitus cause multidirectional changes in IGF and IGFBP levels in the liver of females and unidirectional changes in the liver of males. Following the growth of Guerin’s carcinoma against the background of diabetes mellitus, sex-specific differences in the content of the studied parameters were minimized. It was shown that diabetes mellitus changed the metabolic profile of the liver in the animals of both sexes.

[1]  J. Oxley,et al.  IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells , 2020, Oncotarget.

[2]  Mina Wang,et al.  Diabetes and cancer: Epidemiological and biological links , 2020, World journal of diabetes.

[3]  B. Knebel,et al.  Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men , 2020, International journal of molecular sciences.

[4]  M. Shams,et al.  Metabolomics of Type 1 and Type 2 Diabetes , 2019, International journal of molecular sciences.

[5]  M. Ruscica,et al.  Ceramides and diabetes mellitus: an update on the potential molecular relationships , 2019, Diabetic medicine : a journal of the British Diabetic Association.

[6]  E. Metter,et al.  The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies , 2019, International journal of cancer.

[7]  Simin Liu,et al.  Sex differences, endogenous sex‐hormone hormones, sex‐hormone binding globulin, and exogenous disruptors in diabetes and related metabolic outcomes , 2018, Journal of diabetes.

[8]  Pengcheng Zhu,et al.  Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy. , 2018, Cellular immunology.

[9]  Yutaka Takahashi The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver , 2017, International journal of molecular sciences.

[10]  O. Franco,et al.  Associations of Steroid Sex Hormones and Sex Hormone–Binding Globulin With the Risk of Type 2 Diabetes in Women: A Population-Based Cohort Study and Meta-analysis , 2016, Diabetes.

[11]  K. Collins The Diabetes-Cancer Link , 2014, Diabetes Spectrum.

[12]  D. Tompkins,et al.  Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. , 2014, Gynecologic oncology.

[13]  N. Weiss,et al.  Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. , 2006, American journal of epidemiology.

[14]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[15]  R. Norton,et al.  IGF-binding proteins – the pieces are falling into place , 2005, Trends in Endocrinology & Metabolism.